As of November 2024 Kymera Therapeutics has a market cap of $2.98 Billion USD. This makes Kymera Therapeutics the world's 3588th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Oct 31st, 2024 the market cap of Kymera Therapeutics was reported to be: